Drug Shortage Report for ADDYI
| Report ID | 256352 |
| Drug Identification Number | 02473550 |
| Brand name | ADDYI |
| Common or Proper name | Addyi 100MG |
| Company Name | SPROUT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FLIBANSERIN |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 tablets |
| ATC code | G02CX |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2025-05-01 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2025-10-01 |
| Shortage status | Resolved |
| Updated date | 2025-10-02 |
| Company comments | DIN transferred |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 260-4350 LASSITER AT NORTH HILLS AVE RALEIGH, NORTH CAROLINA UNITED STATES 27609 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-10-02 | English | Compare |
| v6 | 2025-10-01 | French | Compare |
| v5 | 2025-10-01 | English | Compare |
| v4 | 2025-07-23 | French | Compare |
| v3 | 2025-07-23 | English | Compare |
| v2 | 2025-05-02 | French | Compare |
| v1 | 2025-05-02 | English | Compare |
Showing 1 to 7 of 7